Live Q&A: Why Xcellerant Ventures Backed Rejuvenate Bio

​Most VCs don't tell you why they said yes. On September 22, you'll hear it straight from the source.

​John Shufeldt, Founder of Xcellerant Ventures and the Jetstream Venture Fund, sits down with Rejuvenate Bio Co-Founder and CEO Dan Oliver for a candid conversation on both sides of the deal: why Xcellerant backed Rejuvenate Bio, and why Dan chose them as partners.

​During the session we'll cover:

• ​What Rejuvenate Bio is building, and what Xcellerant Ventures is

• ​What Xcellerant looked for before committing, and what convinced them

• ​Why Dan chose to bring Xcellerant into Rejuvenate Bio's cap table

• ​The opportunity ahead, for both Xcellerant and for Rejuvenate Bio

• ​Live Q&A with Dan and John

​Rejuvenate Bio is developing one-time gene therapies that reverse age-related disease, starting in dogs, with the science and the revenue funding a path to humans.

​We're closing in on being oversubscribed for the second time. Invest today and secure your spot alongside Xcellerant Ventures and our other institutional backers: wefunder.com/rejuvenatebio/invest